Literature DB >> 30317643

Small-molecule-based generation of functional cardiomyocytes from human umbilical cord-derived induced pluripotent stem cells.

Kai Hong Wu1, Su Yun Wang1, Qian Ru Xiao2, Yu Yang1, Ning Ping Huang2, Xu Ming Mo1, Jian Sun1.   

Abstract

The purpose of this study was to investigate the cardiac-differentiation potential of induced pluripotent stem cells (iPSCs) generated from human umbilical cord-derived mesenchymal cells. Spontaneous beating colonies were observed at day 7 after the sequential addition of CHIR99021 and IWP-4. The combined use of CHIR99021 and IWP-4 downregulated the expression of pluripotency markers while upregulating cardiac transcription factors and cardiomyocyte-specific markers. The derived cardiomyocytes demonstrated typical sarcomeric structures and action-potential features; most importantly, the derived cells exhibited responsiveness to β-adrenergic and muscarinic stimulations. The analyses of molecular, structural, and functional properties revealed that the derived cardiomyocytes were similar to cardiomyocytes derived from BJ foreskin fibroblast cells. In summary, our results demonstrate that functional cardiomyocytes can be generated from human umbilical cord-derived cells. The methodology described here has potential as a means for the production of functional cardiomyocytes from discarded human umbilical cord tissue.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiomyocyte; differentiation; human umbilical cord; induced pluripotent stem cells; small molecule

Year:  2018        PMID: 30317643     DOI: 10.1002/jcb.27094

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  1 in total

1.  Human umbilical cord mesenchymal stem cell promotes angiogenesis via integrin β1/ERK1/2/HIF-1α/VEGF-A signaling pathway for off-the-shelf breast tissue engineering.

Authors:  Mian Wu; Lifeng Chen; Yuhan Qi; Hai Ci; Shan Mou; Jie Yang; Qiaoyu Yuan; Weiqi Yao; Zhenxing Wang; Jiaming Sun
Journal:  Stem Cell Res Ther       Date:  2022-03-07       Impact factor: 6.832

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.